Samsung launches 200B-won fund to boost biotech sector, eyes global startups
Samsung Group has established a new 200-billion-won investment fund dedicated to discovering innovative biotechnology companies.
Samsung Mulsaun, Samsung Biologics, and Samsung Bioepis jointly pooled resources to complete the formation of the Samsung Life Science Fund III (SVIC-80), Samsung Biologics announced on June 1. The fund centers on aggressively sco..